Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
3 studies found for:    22784038 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Connecting Resources for Urban Sexual Health
Conditions: HIV;   Sexually Transmitted Infections
Interventions: Other: Testing and linkage to care for Y/MSM;   Behavioral: Engagement and retention for HIV-positive Y/MSM in care;   Other: Engagement and retention for HIV-negative Y/MSM in sexual health services
2 Not yet recruiting Phase II Safety and Acceptability of an Investigational Injectable Product, TMC278LA, for Pre-Exposure Prophylaxis
Condition: Human Immunodeficiency Virus (HIV)
Interventions: Drug: Rilpivirine;   Drug: Placebo
3 Completed Botswana TDF/FTC Oral HIV Prophylaxis Trial
Condition: HIV Infections
Interventions: Drug: Tenofovir Disoproxil Fumarate 300 mg + Emtricitabine 200 mg;   Drug: TDF-FTC placebo

Indicates status has not been verified in more than two years